{"id":"W4390640719","doi":"10.1016/j.eururo.2023.12.004","title":"Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Medical Research Council; Advanced Accelerator Applications; Novartis; Endocyte; Genentech; Novartis Pharmaceuticals Corporation; Pfizer; Amgen","keywords":"Medicine; Prostate cancer; Oncology; Castration; Internal medicine; Prostate; Urology; Cancer; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003318262,0.000116407,0.0002852959,0.0001559806,0.00003226211,0.000008467561,0.00008946415,0.0000175826,0.00009048144],"category_scores_gemma":[0.0000573922,0.00005941827,0.00007089278,0.0004107766,0.000202177,0.00005040092,0.00004386156,0.0001683073,0.000004986618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005265695,"about_ca_system_score_gemma":0.0002557425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001205492,"about_ca_topic_score_gemma":0.00007476869,"domain_scores_codex":[0.9985325,0.0003841282,0.0003889407,0.0002273185,0.0002824154,0.0001847045],"domain_scores_gemma":[0.9994009,0.00009581029,0.0001085351,0.0002369436,0.0001102111,0.00004758385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7750349,0.006044718,0.06080931,0.00136102,0.002400552,0.001103148,0.005770619,0.001340986,0.06694721,0.000281481,0.001432391,0.07747366],"study_design_scores_gemma":[0.3406253,0.03465327,0.5978065,0.000793002,0.001747371,0.00001188765,0.0002453351,0.0009577437,0.01466792,0.00008301961,0.008069358,0.0003393598],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955982,0.001052059,0.00001041427,0.0008375597,0.0001579587,0.0009402712,0.0001389021,0.00001186527,0.001252786],"genre_scores_gemma":[0.9992052,0.0001347243,0.00003990566,0.0000484371,0.00003579171,0.00001467762,0.000057031,0.00002265328,0.0004415984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5369972,"threshold_uncertainty_score":0.2423007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04212275365310404,"score_gpt":0.3882628195143704,"score_spread":0.3461400658612663,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}